AstraZeneca's Datroway Approved in US for Lung Cancer
Ticker: AZN · Form: 6-K · Filed: Jun 24, 2025 · CIK: 901832
| Field | Detail |
|---|---|
| Company | Astrazeneca PLC (AZN) |
| Form Type | 6-K |
| Filed Date | Jun 24, 2025 |
| Risk Level | low |
| Sentiment | bullish |
Sentiment: bullish
Topics: drug-approval, lung-cancer, pharmaceuticals
TL;DR
AstraZeneca's Datroway gets US green light for EGFRm NSCLC.
AI Summary
AstraZeneca PLC announced on June 24, 2025, that its drug Datopotamab deruxtecan (Datroway) has been approved in the US for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with a specific genetic mutation. This approval marks a significant advancement for patients with this type of lung cancer.
Why It Matters
This US approval for Datroway offers a new treatment option for patients with a specific type of lung cancer, potentially improving outcomes and expanding therapeutic choices.
Risk Assessment
Risk Level: low — This filing is an informational report of a regulatory approval and does not contain information that would typically indicate a high-risk event.
Key Players & Entities
- AstraZeneca PLC (company) — Filer of the report and developer of the drug
- Datopotamab deruxtecan (drug) — Drug approved in the US
- Datroway (drug) — Brand name for Datopotamab deruxtecan
- non-small cell lung cancer (NSCLC) (disease) — Condition the drug treats
- June 24, 2025 (date) — Date of the filing and approval announcement
FAQ
What is the specific indication for Datroway's US approval?
Datroway (Datopotamab deruxtecan) has been approved in the US for adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with specific genetic mutations.
What is the filing date of this report?
The filing date of this report is June 24, 2025.
What is the SEC file number for AstraZeneca PLC?
The SEC file number for AstraZeneca PLC is 001-11960.
What is the primary business of AstraZeneca PLC?
AstraZeneca PLC is in the Pharmaceutical Preparations industry, SIC code 2834.
What is the former name of AstraZeneca PLC?
The former name of AstraZeneca PLC was ZENECA GROUP PLC, with a date of name change on April 22, 1993.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 24, 2025 regarding ASTRAZENECA PLC (AZN).